Calpain fosters the hyperexcitability of motoneurons after spinal cord injury and leads to spasticity

Abstract

Up-regulation of the persistent sodium current (INaP) and down-regulation of the potassium/chloride extruder KCC2 lead to spasticity after spinal cord injury (SCI). We here identified calpain as the driver of the up- and down-regulation of INaP and KCC2, respectively, in neonatal rat lumbar motoneurons. Few days after SCI, neonatal rats developed behavioral signs of spasticity with the emergence of both hyperreflexia and abnormal involuntary muscle contractions on hindlimbs. At the same time, in vitro isolated lumbar spinal cords became hyperreflexive and displayed numerous spontaneous motor outputs. Calpain-I expression paralleled with a proteolysis of voltage-gated sodium (Nav) channels and KCC2. Acute inhibition of calpains reduced this proteolysis, restored the motoneuronal expression of Nav and KCC2, normalized INaP and KCC2 function, and curtailed spasticity. In sum, by up- and down-regulating INaP and KCC2, the calpain-mediated proteolysis of Nav and KCC2 drives the hyperexcitability of motoneurons which leads to spasticity after SCI.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for all Figures and Supplementary Figures of the manuscript.

Article and author information

Author details

  1. Vanessa Plantier

    Institut de Neurosciences de la Timone, CNRS Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Irene Sanchez-Brualla

    Institut de Neurosciences de la Timone, CNRS Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Nejada Dingu

    Institut de Neurosciences de la Timone, CNRS Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Cécile Brocard

    Institut de Neurosciences Timone UMR7289, CNRS Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Sylvie Liabeuf

    Institut de Neurosciences de la Timone, CNRS Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Florian Gackière

    Institut de Neurosciences de la Timone, CNRS Aix Marseille University, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Frédéric Brocard

    Institut de Neurosciences de la Timone, CNRS Aix Marseille University, Marseille, France
    For correspondence
    frederic.brocard@univ-amu.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9444-9586

Funding

Agence Nationale de la Recherche (ANR CalpaSCI-16-CE16-0004)

  • Frédéric Brocard

Institut Recherche sur la Moelle Epiniere (SPV/MB/173439)

  • Frédéric Brocard

Fondation pour la Recherche Médicale (FDT20170437125)

  • Frédéric Brocard

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Jan-Marino Ramirez, Seattle Children's Research Institute, United States

Ethics

Animal experimentation: We made all efforts to minimize animal suffering and the number of animals used. All animal care and use conformed to the French regulations (Décret 2010-118) and were approved by the local ethics committee (Comité d'Ethique en Neurosciences INT-Marseille, CE Nb A1301404, authorization Nb 2018110819197361).

Version history

  1. Received: August 27, 2019
  2. Accepted: December 8, 2019
  3. Accepted Manuscript published: December 9, 2019 (version 1)
  4. Version of Record published: December 23, 2019 (version 2)

Copyright

© 2019, Plantier et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,410
    Page views
  • 224
    Downloads
  • 18
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Vanessa Plantier
  2. Irene Sanchez-Brualla
  3. Nejada Dingu
  4. Cécile Brocard
  5. Sylvie Liabeuf
  6. Florian Gackière
  7. Frédéric Brocard
(2019)
Calpain fosters the hyperexcitability of motoneurons after spinal cord injury and leads to spasticity
eLife 8:e51404.
https://doi.org/10.7554/eLife.51404

Share this article

https://doi.org/10.7554/eLife.51404

Further reading

    1. Neuroscience
    Kiwamu Kudo, Kamalini G Ranasinghe ... Srikantan S Nagarajan
    Research Article

    Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-β and misfolded tau proteins causing synaptic dysfunction, and progressive neurodegeneration and cognitive decline. Altered neural oscillations have been consistently demonstrated in AD. However, the trajectories of abnormal neural oscillations in AD progression and their relationship to neurodegeneration and cognitive decline are unknown. Here, we deployed robust event-based sequencing models (EBMs) to investigate the trajectories of long-range and local neural synchrony across AD stages, estimated from resting-state magnetoencephalography. The increases in neural synchrony in the delta-theta band and the decreases in the alpha and beta bands showed progressive changes throughout the stages of the EBM. Decreases in alpha and beta band synchrony preceded both neurodegeneration and cognitive decline, indicating that frequency-specific neuronal synchrony abnormalities are early manifestations of AD pathophysiology. The long-range synchrony effects were greater than the local synchrony, indicating a greater sensitivity of connectivity metrics involving multiple regions of the brain. These results demonstrate the evolution of functional neuronal deficits along the sequence of AD progression.

    1. Medicine
    2. Neuroscience
    Luisa Fassi, Shachar Hochman ... Roi Cohen Kadosh
    Research Article

    In recent years, there has been debate about the effectiveness of treatments from different fields, such as neurostimulation, neurofeedback, brain training, and pharmacotherapy. This debate has been fuelled by contradictory and nuanced experimental findings. Notably, the effectiveness of a given treatment is commonly evaluated by comparing the effect of the active treatment versus the placebo on human health and/or behaviour. However, this approach neglects the individual’s subjective experience of the type of treatment she or he received in establishing treatment efficacy. Here, we show that individual differences in subjective treatment - the thought of receiving the active or placebo condition during an experiment - can explain variability in outcomes better than the actual treatment. We analysed four independent datasets (N = 387 participants), including clinical patients and healthy adults from different age groups who were exposed to different neurostimulation treatments (transcranial magnetic stimulation: Studies 1 and 2; transcranial direct current stimulation: Studies 3 and 4). Our findings show that the inclusion of subjective treatment can provide a better model fit either alone or in interaction with objective treatment (defined as the condition to which participants are assigned in the experiment). These results demonstrate the significant contribution of subjective experience in explaining the variability of clinical, cognitive, and behavioural outcomes. We advocate for existing and future studies in clinical and non-clinical research to start accounting for participants’ subjective beliefs and their interplay with objective treatment when assessing the efficacy of treatments. This approach will be crucial in providing a more accurate estimation of the treatment effect and its source, allowing the development of effective and reproducible interventions.